A trusted colleague referred a client to iuvo. The client was looking for a small preclinical consulting project, but the needs of the project expanded to a broader working relationship.
While the initial consulting agreement was focused on a small scope – reviewing a few protocols – the needs of the company and iuvo’s ability to meet those needs evolved into a much more extensive engagement. After an initial engagement, iuvo was added to the Project Core Team as the Preclinical Lead in charge of developing the entire preclinical strategy, authoring the preclinical portion of the pre-IND package, and placing IND-enabling studies at various vendors. Additionally, iuvo’s Formulation and Analytical teams worked with the Client to develop the GLP formulation (and concurrent stability program), and iuvo’s internal Toxicology group conducted a number of supportive toxicology studies.
The relationship expanded greatly, and as a result of the collaboration and iuvo’s expertise in drug development, the Project Team met all corporate goals and initiated early clinical work on time.